Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
Pro, B., Advani, R., Brice, P., Bartlett, N. L., Rosenblatt, J. D., Illidge, T., Matous, J., Ramchandren, R., Fanale, M., Connors, J. M., Yang, Y., Sievers, E. L., Kennedy, D. A., Shustov, A.Volume:
30
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2011.38.0402
Date:
June, 2012
File:
PDF, 395 KB
english, 2012